331 related articles for article (PubMed ID: 11831203)
1. Commentary: the reality of treating HIV and AIDS in poor countries.
Sykes R
BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203
[No Abstract] [Full Text] [Related]
2. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
3. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
[No Abstract] [Full Text] [Related]
4. An unequal activism for an unequal epidemic?
Selemogo M
Dev World Bioeth; 2005 May; 5(2):153-68. PubMed ID: 15842724
[TBL] [Abstract][Full Text] [Related]
5. Improving access to essential drugs for people living with HIV/AIDS.
Balasubramaniam K
Issues Med Ethics; 2000; 8(1):26-7. PubMed ID: 16323335
[No Abstract] [Full Text] [Related]
6. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
[No Abstract] [Full Text] [Related]
7. Public health. Global HIV/AIDS policy in transition.
Bongaarts J; Over M
Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
[No Abstract] [Full Text] [Related]
8. Access to HIV drugs: are we changing the two world paradigm?
Lazzarini Z
Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
[No Abstract] [Full Text] [Related]
9. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
Berger JM
Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
[No Abstract] [Full Text] [Related]
10. Initiative to promote access to quality HIV medicines releases first batch of results today.
J Adv Nurs; 2002 Aug; 39(3):215. PubMed ID: 12174834
[No Abstract] [Full Text] [Related]
11. Essential AIDS medications in India.
Thomas J
Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350
[No Abstract] [Full Text] [Related]
12. New resolution on HIV/AIDS announced at the 53rd World Health Assembly.
Whyte B
Bull World Health Organ; 2000; 78(6):863. PubMed ID: 10916927
[No Abstract] [Full Text] [Related]
13. HHS awards $845.7 million in grants for HIV/AIDS care.
Health Care Financ Rev; 2001; 22(4):213. PubMed ID: 12378779
[No Abstract] [Full Text] [Related]
14. Dose reduction of antiretrovirals: a feasible and testable approach to expand HIV treatment in developing countries.
Vento S; Lanzafame M; Lattuada E; Cainelli F; Restelli U; Foglia E
Trop Med Int Health; 2013 Jan; 18(1):40-4. PubMed ID: 23094787
[No Abstract] [Full Text] [Related]
15. Cheap HIV drugs for developing countries.
Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820
[No Abstract] [Full Text] [Related]
16. "No turning back" on cheap AIDS drugs for poor nations, UN vows.
Silversides A
CMAJ; 2003 Nov; 169(10):1067. PubMed ID: 14609992
[No Abstract] [Full Text] [Related]
17. Drugs for the developing world.
GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
[TBL] [Abstract][Full Text] [Related]
18. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
James JS
AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
[TBL] [Abstract][Full Text] [Related]
19. Affordable access to essential medication in developing countries: conflicts between ethical and economic imperatives.
Schüklenk U; Ashcroft RE
J Med Philos; 2002 Apr; 27(2):179-95. PubMed ID: 11961696
[TBL] [Abstract][Full Text] [Related]
20. Uganda cuts AIDS drug deal.
IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022
[No Abstract] [Full Text] [Related]
[Next] [New Search]
